Hypersensitivity: FDA reporting patterns
182,894 FDA FAERS reports mention Hypersensitivity. 96,644 reports have a serious outcome flag.
Medicines named as suspect
- Etanercept: 13,870 reports
- Adalimumab: 12,864 reports
- Methotrexate: 10,335 reports
- Infliximab: 10,285 reports
- Tocilizumab: 9,625 reports
- Abatacept: 9,486 reports
- Rituximab: 9,377 reports
- Adapalene: 8,500 reports
- Leflunomide: 8,338 reports
- Acetaminophen: 8,000 reports
- Certolizumab Pegol: 7,843 reports
- Octisalate: 7,268 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.